BioVenture is headquartered inside Suzhou BioBay, one of China's top biotech innovation parks, and uses BioBay as both a deal-flow engine and post-investment service platform rather than operating as a standalone financial investor. The fund operates a portfolio-based network of 180-200+ companies (mostly in China) with many physically co-located in BioBay, emphasizing intra-portfolio collaboration and business development synergies as a deliberate value-creation mechanism.